IMD device study for certain head and neck cancers
Part of Cancer, Mouth & dental clinical trials.
This early-phase study tests a new small device (placed through the skin) plus standard surgery to study head and neck cancers. It may help researchers understand how the device works and gather safety information for people who need definitive surgery for a measurable tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed head and neck cancer: salivary cancer (including ACC) or squamous cell carcinoma
- Your cancer is not currently recurrent (coming back), not spread (metastatic), and is in a stage where it can be treated with planned surgery
- You are 18 years or older, and your day-to-day functioning is good (ECOG 0 or 1)
- You have a measurable tumor you can see on scans that is at least 1 cm by 1 cm
- Your recent blood tests are safe for procedures: platelets ≥50,000, and clotting tests are not too high (PT/INR <2 and aPTT <1.5× normal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.
This study uses advanced tests on tissue and blood samples to understand why adenoid cystic carcinoma (a type of head and neck cancer) spreads. It aims to find new clues that may help improve future treatments.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This trial tests a combination of two immunotherapy drugs (IBI110 and sintilimab) with chemotherapy before surgery for people with advanced head and neck cancer that can be removed surgically. The goal is to see if this approach helps shrink tumors and improve outcomes.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
Hear when a new Salivary Gland Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.